Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Y Choo

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Cycle (Georgetown, Tex.)|February 7, 2009
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapyAndrew Y Choo, John Blenis
Cancer Cell|February 14, 2006
TORgeting oncogene addiction for cancer therapyAndrew Y Choo, John Blenis
Molecular Cell|November 25, 2010
ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulationSang Gyun Kim, Andrew Y Choo, John Blenis
Cell|September 9, 2006
Mind the GAP: Wnt steps onto the mTORC1 trainAndrew Y Choo, Philippe P Roux, John Blenis
Idrugs : the Investigational Drugs Journal|September 30, 2010
DNA-based influenza vaccines: evaluating their potential to provide universal protectionAndrew Y Choo, Kate E Broderick, Joseph J Kim, et al.
Current Drug Delivery|November 25, 2005
HIV-1 Vpr: enhancing sensitivity of tumors to apoptosisKaruppiah Muthumani, Andrew Y Choo, Daniel S Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2008
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationAndrew Y Choo, Sang-Oh Yoon, Sang Gyun Kim, et al.
International Immunology|December 22, 2004
HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitroKaruppiah Muthumani, Daniel S Hwang, Andrew Y Choo, et al.
Virology|October 1, 2003
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivoKaruppiah Muthumani, Donghui Zhang, Nathanael S Dayes, et al.
Molecular Cell|June 2, 2010
Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supplyAndrew Y Choo, Sang Gyun Kim, Matthew G Vander Heiden, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|February 7, 2009
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapyAndrew Y Choo, John Blenis
Cancer Cell|February 14, 2006
TORgeting oncogene addiction for cancer therapyAndrew Y Choo, John Blenis
Molecular Cell|November 25, 2010
ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulationSang Gyun Kim, Andrew Y Choo, John Blenis
Cell|September 9, 2006
Mind the GAP: Wnt steps onto the mTORC1 trainAndrew Y Choo, Philippe P Roux, John Blenis
Idrugs : the Investigational Drugs Journal|September 30, 2010
DNA-based influenza vaccines: evaluating their potential to provide universal protectionAndrew Y Choo, Kate E Broderick, Joseph J Kim, et al.
Current Drug Delivery|November 25, 2005
HIV-1 Vpr: enhancing sensitivity of tumors to apoptosisKaruppiah Muthumani, Andrew Y Choo, Daniel S Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2008
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationAndrew Y Choo, Sang-Oh Yoon, Sang Gyun Kim, et al.
International Immunology|December 22, 2004
HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitroKaruppiah Muthumani, Daniel S Hwang, Andrew Y Choo, et al.
Virology|October 1, 2003
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivoKaruppiah Muthumani, Donghui Zhang, Nathanael S Dayes, et al.
Molecular Cell|June 2, 2010
Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supplyAndrew Y Choo, Sang Gyun Kim, Matthew G Vander Heiden, et al.
Pageof 3